| NCT Number | NCT07442578 |
| Lead Sponsor | Dana-Farber Cancer Institute |
| Conditions | Childhood Cancer Survivors, Cardiotoxicity, Cardiovascular Diseases, Anthracycline-induced Cardiotoxicity |
| Enrollment | 20 participants |
| Start Date | 2026-03-04 |
| Primary Completion | 2027-03-04 (estimated) |
| Study Completion | 2028-03-04 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-18 |